Drug Database
Back to search

France· FR:62723129

FUZEON 90 mg/ml, poudre et solvant pour solution injectable

A enfuvirtide product containing enfuvirtide, registered in France by ROCHE REGISTRATION (ALLEMAGNE), on the national reimbursement list. The same ATC class is registered in 10 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC J05AX07

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedFUZEON 90 mg/ml, poudre et solvant po…ATCJ05AX07REGISTER NO.FR:62723129PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about enfuvirtideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Enfuvirtide is registered in 10 of 19 countries.

Countries holding a registration under ATC J05AX07 (enfuvirtide), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 6 of them publish a price we can compare per daily dose
Search enfuvirtide products by name

Enfuvirtide · ATC J05AX07

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
ENFUVIRTIDE
Manufacturer
ROCHE REGISTRATION (ALLEMAGNE)
Country
France (FR)
ATC code
J05AX07
ATC class
Enfuvirtide
Defined daily dose
0.18 g, P
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400936221857
    60 flacon(s) en verre - 60 flacon(s) en verre de 2 ml avec 60 seringue(s) de 3 ml avec 60 seringue(s) de 1 ml avec 180 tampon(s) alcoolisé(s)
    EUR 1.66

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

2 interactions on record for enfuvirtide.

Graded by severity as the source publishes them — 2 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check enfuvirtide against other medicinesHow interaction checks work

Enfuvirtide · interactions on record

2 records

  • 2 moderate

Most severe, free to view

  • Darunavir and cobicistatJ05AR14moderate
  • CobicistatV03AX03moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Enfuvirtide in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All enfuvirtide products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Fuzeon
  • Liechtenstein · Fuzeon
  • Norway · Fuzeon

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/4f8a5643-7ba5-47b7-bc62-490df6c94d38
GET /v1/drugs/4f8a5643-7ba5-47b7-bc62-490df6c94d38?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "62723129",
  "date_amm": "2003-05-27",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/03/252",
  "substance": "ENFUVIRTIDE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": "Warning disponibilité",
  "forme_pharmaceutique": "poudre et  solvant pour solution injectable",
  "voies_administration": "sous-cutanée",
  "etat_commercialisation": "Non commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about enfuvirtide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console